Literature DB >> 18452551

Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture.

Karin Roberg1, Rebecca Ceder, Lovisa Farnebo, Lena Norberg-Spaak, Roland C Grafström.   

Abstract

Oral squamous cell carcinoma (OSCC) lines proliferative in the serum-free conditions devised for normal oral keratinocytes (NOK) are virtually absent, complicating studies of carcinogenesis. A tongue squamous cell carcinoma generated under conditions for normal cell culture an apparently immortal line (termed LK0412) that has undergone >or=200 population doublings from over a year in culture. LK0412 exhibited epithelial morphology, intermediate filaments, desmosomes, and cytokeratin. Soft agar growth and tumorigenicity in athymic nude mice indicated the malignant phenotype. Compared with NOK, LK0412 exhibited increased indices for proliferation and apoptosis, and a decreased terminal differentiation index. Fetal bovine serum inhibited growth and increased apoptosis but failed to induce terminal differentiation of LK0412; the latter outcome differed clearly from that in NOK. Gene ontology assessment of transcript profiles implicated multiple alterations in biological processes, molecular functions, and cellular components in LK0412. Genetic changes, some that were confirmed to the protein level, included previously proposed OSCC markers, i.e., BAX, CDC2, and TP53, as well as multiple cancer-associated genes not considered for OSCC, e.g., BST2, CRIP1, ISG15, KLRC1, NEDD9, NNMT, and TWIST1. Elevation of p53 protein agreed with a missense mutation detectable in both the LK0412 line and the original tumor specimen. Moderate differentiation characterized the original tumor as well as tumors generated from inoculation of LK0412 in mice. Overall, the results suggest that the LK0412 cell line represent a subgroup of OSCC with unique genomic and phenotypic profiles. LK0412 should be useful to exploration of OSCC development, particularly the deregulated growth and differentiation responsiveness to serum factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452551     DOI: 10.1111/j.1432-0436.2008.00267.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  8 in total

1.  Cell culture of human gingival fibroblasts, oral cancer cells and mesothelioma cells with serum-free media, STK1 and STK2.

Authors:  Yuta Tsugeno; Fuyuki Sato; Yasuteru Muragaki; Yukio Kato
Journal:  Biomed Rep       Date:  2014-06-27

2.  WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.

Authors:  S Mahmoudi; S Henriksson; L Farnebo; K Roberg; M Farnebo
Journal:  Cell Death Dis       Date:  2011-01-13       Impact factor: 8.469

3.  Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma.

Authors:  Wusheng Yan; Joanna H Shih; Jaime Rodriguez-Canales; Michael A Tangrea; Kris Ylaya; Jason Hipp; Audrey Player; Nan Hu; Alisa M Goldstein; Philip R Taylor; Michael R Emmert-Buck; Heidi S Erickson
Journal:  BMC Res Notes       Date:  2012-01-26

Review 4.  Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review.

Authors:  Lucrezia Togni; Marco Mascitti; Davide Sartini; Roberto Campagna; Valentina Pozzi; Eleonora Salvolini; Annamaria Offidani; Andrea Santarelli; Monica Emanuelli
Journal:  Biomolecules       Date:  2021-10-28

Review 5.  Nicotinamide N-Methyltransferase in Health and Cancer.

Authors:  David B Ramsden; Rosemary H Waring; David J Barlow; Richard B Parsons
Journal:  Int J Tryptophan Res       Date:  2017-06-30

6.  A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.

Authors:  Linnea La Fleur; Ann-Charlotte Johansson; Karin Roberg
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

7.  Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death.

Authors:  Jaganmohan R Jangamreddy; Mayur V Jain; Anna-Lotta Hallbeck; Karin Roberg; Kourosh Lotfi; Marek J Łos
Journal:  Oncotarget       Date:  2015-04-30

8.  In vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET/CT.

Authors:  Natasa Matic; Marcus Ressner; Emilia Wiechec; Karin Roberg
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.